In order to assess the effect of DATS on CSC in tumors, it was analyzed for ALDH1 activity: Figure 6G shows flow histograms for ALDH1 activity in tumor cells from the control and DATS treatment groups. The gene discussed is ALDH1A1; the disease is neoplasm.